Table 2.
Systemic Therapies Received by Patients with Severe Psoriasis (n= 3603)*
| Systemic Therapy | Number of Patients with Severe Psoriasis (%) |
|---|---|
| Methotrexate | 2114 (58.7%) |
| Psoralen | 607 (16.9%) |
| Azathioprine | 582 (16.2%) |
| Cyclosporine | 390 (10.8%) |
| Etretinate or acetretin | 333 (9.2%) |
| Hydroxyurea | 208 (5.8%) |
| Mycophenolate mofetil | 9 (0.3%) |
Percentages do not add up to 100 because patients could have received more than 1 systemic therapy